01 Apr 2022 --- The US Food and Drug Administration (FDA) has rejected industry petitions not to exclude the use of N-acetyl-L-cysteine (NAC) in the definition of dietary supplements. The move has prompted industry to accuse the body of favoring pharma monopolies amid fears of future implications on dietary ingredients.
